Justin R Arnall is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of North Carolina at Chapel HillPharmD, 2014
Publications & Presentations
PubMed
- 6 citationsIncidence and management of adverse events associated with panobinostat in the treatment of relapsed/refractory multiple myeloma.Donald C Moore, Justin Arnall, R. Donald Harvey
Journal of Oncology Pharmacy Practice. 2019-04-01 - 12 citationsDaratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma.M. Junaid Hussain, Myra M. Robinson, Issam Hamadeh, Justin Arnall, Manisha Bhutani
British Journal of Haematology. 2019-07-01 - 5 citationsEnhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses.Justin Arnall, Donald C Moore, Hailey Hill, Sarah A. Griffin, Maxine K Mueller
Leukemia & Lymphoma. 2019-03-08
Office
1021 Morehead Medical Dr
Charlotte, NC 28204Phone+1 704-512-6057Fax+1 980-442-3002
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
